The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
102192073 10219207 3 F 20160711 20140605 20160718 EXP SI-ASTELLAS-2014US006279 ASTELLAS ZWITTER M, RAJER M, STANIC K, VRANKAR M, DOMA A, CUDERMAN A ET AL. INTERCALATED CHEMOTHERAPY AND ERLOTINIB FOR NON-SMALL CELL LUNG CANCER (NSCLC) WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS. CANCER BIOLOGY AND THERAPY. 2016;1-7 0.00 Y 0.00000 20160718 COUNTRY NOT SPECIFIED SI

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
102192073 10219207 1 PS Erlotinib ERLOTINIB 1 Unknown ON DAYS 5 TO 15 (150 MG, 1 IN 3 WK) 21743 150 MG TABLET
102192073 10219207 2 SS Erlotinib ERLOTINIB 1 Unknown UNK, UNKNOWN FREQ. 21743 TABLET
102192073 10219207 3 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Unknown ON DAYS 1 AND 4 (1250 MG/M2, 1 IN 3 WK) U 0 1250 MG/M**2 FORMULATION UNKNOWN
102192073 10219207 4 SS CISPLATIN. CISPLATIN 1 Unknown ON DAY 2 (75 MG/M2, 1 IN 3 WK) U 0 75 MG/M**2 FORMULATION UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
102192073 10219207 1 Non-small cell lung cancer
102192073 10219207 3 Non-small cell lung cancer
102192073 10219207 4 Non-small cell lung cancer

Outcome of event

Event ID CASEID OUTC COD
102192073 10219207 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
102192073 10219207 Neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found